Navigation Links
Frontiers announces launch of new open-access journal, Frontiers in Public Health
Date:3/21/2013

Frontiers, one of the world's fastest-growing Open Access publishers and among the largest social networking platforms for researchers, announces the launch of a new journal, Frontiers in Public Health.

Frontiers in Public Health will publish high quality, rigorously peer-reviewed articles on the most outstanding discoveries and leading thoughts across the entire research spectrum of Public Health.

On the Frontiers interactive web platform, diverse and emerging research areas will come together to empower the public health community to steer research, policy, debate and intervention toward the future, with a range of open research and communication tools.

Frontiers recently announced a strategic partnership with Nature Publishing Group, to bring its publishing model for interactive peer review and open science communication to the field of public and global health. Frontiers in Public Health will join Frontiers' other highly successful journals in medicine and the life sciences, including such widely read titles as Frontiers in Neuroscience.

Frontiers in Public Health is now open for submissions! Initial sections, with more to follow, include:

  • Frontiers in Child Health and Human Development (Editor-in-Chief: Joav Merrick)
  • Frontiers in Epidemiology (Editor-in-Chief: Jimmy Efird)
  • Frontiers in Public Health Education and Promotion (Editors-in-Chief: Connie Evashwick and Marcia Ory)
  • Frontiers in Diabetes (Editor-in-Chief: Aaron Vinik)
  • Frontiers in HIV/AIDS (Editor-in-Chief: Frank Miedema)
  • Frontiers in Immunotherapies and Vaccines (Editor-in-Chief: Jean-Luc Teillaud)

Frontiers' real-time and interactive peer review enables fast, fair and constructive review of a range of article types. With an average of three months from submission to final decision for a paper, articles are published quickly, under the Creative Commons Attribution (CC-BY) license, and are freely available to an international audience.

"Publishing high quality, peer reviewed papers on a fast and rolling basis with a strong international reach is of paramount importance to the public health research community," said Prof. Joav Merrick, Editor-in-Chief of Frontiers in Public Health, and the founder and Director of the National Institute of Child Health and Human Development in Israel.

"Frontiers' focus on harnessing the indispensable power of the internet and growing range online tools to carry out peer review, publication and dissemination of research will equip public health researchers to make the profound changes that are expected of them today," explained Prof. Merrick.

"Authors will retain copyright to their work, and the use of the Creative Commons Attribution license means that there will be no barriers to disseminating research as quickly, efficiently and widely as possible for the benefits of not only the scholarly community, but also for policy-makers, non-governmental organizations, citizens and patients globally," he added.

Authors are welcome to submit any of the following article types to Frontiers in Public Health: Book Review, Classification, Clinical Case Study, Clinical Trial, CPC, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, and Technology Report.


'/>"/>

Contact: Gozde Zorlu
gozde.zorlu@frontiersin.org
Frontiers
Source:Eurekalert

Related biology news :

1. Finding new research frontiers in a single cell
2. Elsevier announces the launch of a new journal: Wound Medicine
3. Pew announces 2013 Marine Fellows
4. St. Jude Childrens Research Hospital announces issuance of US patent for cancer therapy
5. Labrys Biologics Announces Key Executive Appointments
6. Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia
7. Wake Forest Innovations Announces New Commercialization Developments
8. Elsevier announces the launch of a new journal: Methods in Oceanography
9. Sloan Foundation announces 2013 Sloan Research Fellows
10. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
11. Elsevier announces the launch of a new journal: Journal of Forensic Radiology and Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
(Date:11/15/2016)... Md. , Nov. 15, 2016  Synthetic ... company developing therapeutics focused on the gut microbiome, ... offering of 25,000,000 shares of its common stock ... common stock at a price to the public ... proceeds to Synthetic Biologics from the offering, excluding ...
(Date:11/14/2016)... -- xG Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, ... use in challenging operating environments, announced its results for ... hold a conference call to discuss these results on ... below). Key Recent Accomplishments ... to acquire Vislink Communication Systems. The purchase is expected ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... December 07, 2016 , ... A ... “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not ... patient population and timing of blood sampling may improve the value of a ...
(Date:12/7/2016)... Dec. 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), ... commercialization of immunotherapeutic products for the treatment of ... an Antibody Manufacturing Development Program with Cytovance Biologics ... for its oregovomab antibody product. Supported by recent ... clinical study in ovarian cancer patients, OncoQuest has ...
Breaking Biology Technology: